Contract Service Directory

Catalent Pharma Solutions





Company Headquarters

14 Schoolhouse Road
Somerset, NJ 08873
United States

Company Description

Catalyst + Talent. Our name combines these ideas. Catalent is the global leader in development solutions and advanced drug delivery technologies, providing world-wide clinical and commercial supply capabilities for drugs, biologics, consumer health and animal health products. With over 80 years serving the industry, we have proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable product supply.

Catalent. More products. Better treatments. Reliably supplied.™

Contract Service Directory

    Related Content

    • Breaking News | Formulation Development | Industry News
      Catalent, Ethicann Partner on Fast-Dissolve Treatment

      Catalent, Ethicann Partner on Fast-Dissolve Treatment

      Will leverage Catalent’s Zydis ODT technology to develop a new pharmaceutical-grade CBD and THC product to treat spasticity in MS patients
      12.03.19

    • Assessing Current DSCSA Implementation

      Assessing Current DSCSA Implementation

      A detailed view of the industry’s progress with DSCSA Serialization Requirements.
      Peter Sturtevant, Senior Director Industry Development - Pharmaceuticals, GS1 US 11.22.19

    • Breaking News | cGMP Manufacture | Industry News
      Catalent, BeiGene Enter Long-Term Supply Agreement

      Catalent, BeiGene Enter Long-Term Supply Agreement

      Will manufacture BRUKINSA, a Bruton’s tyrosine kinase (BTK) inhibitor that recently received accelerated approval from the U.S. FDA.
      11.21.19


    • Frontage Laboratories

      Frontage Laboratories' Hugh Davis

      Frontage's chief business officer highlights the CRO's service offerings.
      Contract Pharma Staff

    • Breaking News | Promotions & Moves
      Catalent Appoints Corporate Development and Science Leaders

      Catalent Appoints Corporate Development and Science Leaders

      Mike Grippo will serve as senior vice president, Strategy and Corporate Development, and Julien Meissonnier as vice president and chief scientific officer
      11.19.19

    • Promotions & Moves
      METALL+PLASTIC Appoints New Managing Director

      METALL+PLASTIC Appoints New Managing Director

      Dr. Heuer succeeds Thomas Bertsche, who will be retiring in May 2020
      11.19.19


    • Breaking News | Industry News
      CPhI’s 16th Pharma Awards Winners

      CPhI’s 16th Pharma Awards Winners

      Dr. Ge Li wins ‘CEO of the Year’ and John Chiminski a ‘Lifetime Achievement’ award.
      11.13.19

    • cGMP Manufacture | Drug Development
      Contract Pharma’s 20th Anniversary Series: Catalent

      Contract Pharma’s 20th Anniversary Series: Catalent

      Elliott Berger of Catalent shares his insights on the past 20 years and what we can anticipate for the future of the industry and outsourcing
      Kristin Brooks, Contract Pharma 11.08.19

    • Catalent

      Catalent's Stacey Treichler

      Catalent's product manager for biologics highlights key events.
      Contract Pharma Staff


    • AAPS Exhibitor List

      Company Name Booth # 3D BIOOPTIMA CO., LTD. 1205 AbbVie 2639 AbbVie C1 ABITEC CORPORATION 628 Absorption Systems…
      10.29.19

    • Promotions & Moves
      Catalent Appoints Germany GM

      Catalent Appoints Germany GM

      Guy J. Dewil, M.D. brings significant life sciences and clinical trial leadership experience across operations, business development and product management
      10.03.19

    • Breaking News | cGMP Manufacture | Fill/Finish | Industry News
      Minerva, Catalent Enter Long-Term Commercial Supply Pact

      Minerva, Catalent Enter Long-Term Commercial Supply Pact

      Catalent will manufacture and package the finished dose form of Roluperidone at its facility in Schorndorf, Germany
      09.24.19


    • Contracting And Outsourcing Exhibitor List

      2019 Exhibitors Company Table 3C PACKAGING 138 Adare Pharmaceuticals 97 Adents 123 Admix Pharma Labs 135 Advanced Analytical…
      09.17.19

    • Changing the Face of CDMOs

      Changing the Face of CDMOs

      Looking for tomorrow’s biopharma leaders today.
      Le Ly and Peter Gallagher, Egon Zehnder 09.16.19

    • Breaking News | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer
      Catalent, Acura Enter Clinical Manufacturing Pact

      Catalent, Acura Enter Clinical Manufacturing Pact

      Catalent to scale-up manufacturing of LTX-03 for clinical testing
      09.16.19

    • Industry News
      ContraVir Pharmaceuticals Becomes Hepion Pharmaceuticals

      ContraVir Pharmaceuticals Becomes Hepion Pharmaceuticals

      Trading Symbol Change to “HEPA”
      07.24.19

    • Promotions & Moves
      Catalent Names SVP, Chief HR Officer

      Catalent Names SVP, Chief HR Officer

      Ricardo Pravda brings more than 25 years of global experience across multiple HR disciplines
      07.18.19

    • Breaking News | Facilities | Fill/Finish | Industry News
      Catalent Breaks Ground in Indiana

      Catalent Breaks Ground in Indiana

      $112 million drug product manufacturing facility will increase fill/finish capacity by 79,000 sq. ft.
      07.15.19

    • Promotions & Moves
      Pii Appoints Business Executives

      Pii Appoints Business Executives

      Ideus, Grellner and McFarlane to head market engagement and business management activities
      07.02.19